Benefits
Corrects Chromium Deficiency in TPN
Chromium chloride is used to supply chromium in intravenous and total parenteral nutrition. In rare deficiency cases arising during long-term parenteral nutrition, adding chromium has reversed glucose intolerance and related symptoms, supporting its role in clinical nutrition.
Glucose Metabolism Role
Chromium contributes to normal carbohydrate metabolism and insulin action. The foundational evidence for this role came from chromium chloride supplementation in deficient patients, although routine oral use shows little benefit in people who are not deficient.
Reference Inorganic Form
As the traditional inorganic chromium salt, chromium chloride served as the standard against which newer, better-absorbed chromium forms were compared. This historical role makes it a benchmark for understanding chromium bioavailability.
Parenteral Nutrition Component
Chromium chloride remains a practical, soluble source of chromium for compounding parenteral nutrition trace-element solutions, helping maintain adequate chromium status in patients who cannot eat normally.
Mechanism of action
Low Oral Absorption
Inorganic chromium chloride is absorbed very poorly from the gut (about 0.5-2%), which limits its usefulness as an oral supplement and is the main reason chelated forms such as picolinate were developed to improve uptake.
Insulin Signaling Support
Once absorbed or delivered intravenously, trivalent chromium is proposed to support insulin receptor signaling and glucose uptake, the basis for the improvement seen when chromium was restored in deficient parenteral-nutrition patients.
Direct Systemic Delivery via Infusion
Given intravenously in parenteral nutrition, chromium chloride bypasses poor intestinal absorption and delivers chromium directly to the circulation, which is why the historic deficiency-reversal evidence comes from this route.
Not an Established Essential Nutrient
Despite chromium's classic association with glucose tolerance, current analyses hold that chromium is not clearly essential and has no defined dietary deficiency in healthy people, consistent with the weak effects of oral chromium salts.
Clinical trials
Clinical case report of a patient on long-term total parenteral nutrition who developed glucose intolerance, weight loss, and neuropathy; intravenous chromium chloride supplementation was given and metabolic and neurological responses followed.
Single long-term parenteral nutrition patient.
Chromium supplementation reversed the glucose intolerance, reduced the need for insulin, and improved neuropathy and well-being. This historic case using chromium chloride helped establish chromium's role in glucose metabolism, but it reflects a rare deficiency state, not benefit in well-nourished people.
Randomized, double-blind, placebo-controlled trial of supplemental chromium versus placebo over 6 months in a Western population with type 2 diabetes on oral medication, measuring HbA1c and glycemic control.
Western type 2 diabetes patients on oral therapy.
No difference in HbA1c was found between chromium and placebo, with the authors concluding chromium did not improve glycemic control in this population. The negative result illustrates that, beyond correcting frank deficiency, chromium supplementation has little reliable glycemic benefit.